Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knut Baumann

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Archiv Der Pharmazie|November 26, 2003
Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium typePetra Kapková, Nikolaus Stiefl, Ulf Sürig, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|November 16, 2013
Observer-independent quantification of insulin granule exocytosis and pre-exocytotic mobility by TIRF microscopyMagnus Matz, Kirstin Schumacher, Kathrin Hatlapatka, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|December 6, 2006
Towards a detailed understanding of bacterial metabolism--spectroscopic characterization of Staphylococcus epidermidisUte Neugebauer, Ulrike Schmid, Knut Baumann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 20, 2010
Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German marketTanja Beyer, Magnus Matz, Daniela Brinz, et al.
Chemmedchem|November 27, 2007
Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2Björn Degel, Peter Staib, Sebastian Rohrer, et al.
Metallomics : Integrated Biometal Science|December 6, 2018
A gold(i) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugsClaudia Schmidt, Lucia Albrecht, Shantheya Balasupramaniam, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitorErika Martina, Nikolaus Stiefl, Björn Degel, et al.
European Journal of Medicinal Chemistry|May 8, 2012
2-Anilino-4-(benzimidazol-2-yl)pyrimidines--a multikinase inhibitor scaffold with antiproliferative activity toward cancer cell linesRenate Determann, Jan Dreher, Knut Baumann, et al.
Journal of Medicinal Chemistry|October 28, 2005
A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methodsUlrich Kaeppler, Nikolaus Stiefl, Markus Schiller, et al.
Analytical and Bioanalytical Chemistry|September 9, 2010
Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samplesSusanne Alban, Susanne Lühn, Simone Schiemann, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Archiv Der Pharmazie|November 26, 2003
Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium typePetra Kapková, Nikolaus Stiefl, Ulf Sürig, et al.
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|November 16, 2013
Observer-independent quantification of insulin granule exocytosis and pre-exocytotic mobility by TIRF microscopyMagnus Matz, Kirstin Schumacher, Kathrin Hatlapatka, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|December 6, 2006
Towards a detailed understanding of bacterial metabolism--spectroscopic characterization of Staphylococcus epidermidisUte Neugebauer, Ulrike Schmid, Knut Baumann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 20, 2010
Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German marketTanja Beyer, Magnus Matz, Daniela Brinz, et al.
Chemmedchem|November 27, 2007
Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2Björn Degel, Peter Staib, Sebastian Rohrer, et al.
Metallomics : Integrated Biometal Science|December 6, 2018
A gold(i) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugsClaudia Schmidt, Lucia Albrecht, Shantheya Balasupramaniam, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitorErika Martina, Nikolaus Stiefl, Björn Degel, et al.
European Journal of Medicinal Chemistry|May 8, 2012
2-Anilino-4-(benzimidazol-2-yl)pyrimidines--a multikinase inhibitor scaffold with antiproliferative activity toward cancer cell linesRenate Determann, Jan Dreher, Knut Baumann, et al.
Journal of Medicinal Chemistry|October 28, 2005
A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methodsUlrich Kaeppler, Nikolaus Stiefl, Markus Schiller, et al.
Analytical and Bioanalytical Chemistry|September 9, 2010
Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samplesSusanne Alban, Susanne Lühn, Simone Schiemann, et al.
Pageof 6